Rectal Bioavailability of Δ-9-Tetrahydrocannabinol from the Hemisuccinate Ester in Monkeys
- 1 October 1991
- journal article
- research article
- Published by Elsevier in Journal of Pharmaceutical Sciences
- Vol. 80 (10) , 942-945
- https://doi.org/10.1002/jps.2600801008
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Disposition and Bioavailability of Various Formulations of Tetrahydrocannabinol in the Rhesus MonkeyJournal of Pharmaceutical Sciences, 1985
- Metabolism, disposition, and kinetics of delta-9-tetrahydrocannabinol in men and womenClinical Pharmacology & Therapeutics, 1983
- Cannabichromene and Δ9-tetrahydrocannabinol: Interactions relative to lethality, hypothermia and hexobarbital hypnosisGeneral Pharmacology: The Vascular System, 1981
- Plasma delta-9-tetrahydrocannabinol concentrations and clinical effects after oral and intravenous administration and smokingClinical Pharmacology & Therapeutics, 1980
- Influence of fasting on the absorption and effects of δ9-tetrahydrocannabinol after oral administration in sesame oilPharmacology Biochemistry and Behavior, 1977
- Antiemetic Effect of Delta-9-Tetrahydrocannabinol in Patients Receiving Cancer ChemotherapyNew England Journal of Medicine, 1975
- Intravenous Injection in Man of Δ 9 -Tetrahydrocannabinol and 11-OH-Δ 9 -TetrahydrocannabinolScience, 1972
- Isolation, Structure, and Partial Synthesis of an Active Constituent of HashishJournal of the American Chemical Society, 1964